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1. Introduction 
Peptide mixtures, arising from such diverse sources 
as tissue extracts, urine or proteolysis, are usually 
fractionated and characterized by a combination of 
ion-exchange chromatography, gel-exclusion chro- 
matography and/or electrophoresis. Appropriate 
combinations of these methods will normally yield a 
homogeneous product, but their costs, detection 
limits, analyses times and yields vary. The recently 
introduced technique of high-performance liquid 
chromatography is now being adapted to peptide- 
protein fractionation by numerous laboratories. The 
great versatility of this technique rests in the various 
column materials available for normal-phase adsorption 
(silica), reverse-phase adsorption (hydrocarbon bonded 
to silica) or ion exchange (ionic groups bonded to 
silica or polystyrene). 
To date proteins and large peptide fragments have 
been separated using both ion exchange (CM-glyco- 
phase/CPG [ 1 ] and DEAE-glycophase/CPG [2]) and 
molecular or steric exclusion supports (glycophase 
G/CPG [ 1,2]). Smaller peptides resulting from 
enzymatic hydrolyses [ 1,3-71, solid-phase syntheses 
[8] and tissue extractions [5,6,9,10] have been 
chromatographed and/or isolated using reverse phase 
Cl 8 columns and either isocratic or gradient elution 
systems. The detection systems, in most cases absor- 
bance, limit both the buffer systems which can be 
employed and also the sensitivity. These restrictions 
Abbreviations: DABITC, 4-N,Ndimethylaminoazobenzene 
4’Gsothiocyanate; HPLC, high-performance liquid chromatog- 
raphy; OPA, O-phthaldialdehyde 
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can largely be overcome by diverting a portion of the 
eluant to a ‘peptide’ analyzer and reacting the primary 
amines with ninhydrin [ 111, OPA [ 121 or fluores- 
camine [ 131. 
This article reports the use of HPLC for peptide 
isolation utilizing reverse phase columns. The flexibility 
and reliability of the system derives from the use of 
microprocessor-controlled pumps for gradient forma- 
tion and a peptide-detection system based on fluores- 
camine or OPA. Protein digests of <lOO nmol, where 
100 pmol is required for detection, yield fragments 
which can then be readily sequenced by microse- 
quence analysis on either solid- [ 141 or liquid-phase 
[ 151 instruments. 
2. Materials and methods 
The apparatus, for the analytical or preparative 
separation of peptides, consists of an HPLC system 
connected via a sampling valve to a fluorescence 
detection system. Two Altex pumps (model 1 lo), 
controlled by an Altex microprocessor (model 420), 
delivered the gradient for column elution. Sample 
injection was via a Bheodyne injector (model 70 with 
a 500 ~1 sample loop). The sampling and detection 
systems have been detailed in [ 131. Basically, the 
sampling system consists of a valve which, via an 
electronically controlled pneumatic system and a 
transfer solution (water; flowrate 14 ml/h), removes a 
predeterminable aliquot of the eluant (O-100%). 
This aliquot is then mixed with a buffer and a fluoro- 
genie reagent (detailed below), the resulting fluores- 
cence measured (Gilson Spectra/G10 Fluorometer 
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equipped with a standard flowthrough 65 ~1 cell, 
and fluorescamine excitation-emission filters) and 
recorded (w + W Recorder, model 3 12). The solution 
compositions and their flowrates used in this investi- 
gation, were for fluorescamine detection, borate 
buffer (0.6 M borate titrated to pH 9.6 with saturated 
LiOH and back to pH 9.4 with acetic anhydride, 
2 5 ml; flowrate 28 ml/h) and the fluorescamine 
(Roche) solution (20 mg/lOO ml in acetone; flowrate 
14 ml/h). The single mixture necessary for OPA 
detection was a 0.6 M borate solution titrated to 
pH 10.3 with saturated LiOH prior to the addition of 
2 ml acetic anhydride, 1 ml /?-mercaptoethanol, 2 ml 
30% Brij 35 (Pierce) and 3 ml methanol containing 
200 mg OPA (Sigma); flowrate 28 ml/h. 
Goldfish and human hemoglobins were prepared 
from freshly collected blood. The erythrocytes were 
washed 3 times in ice-cold saline, then lysed hypoton- 
ically. Globin was obtained by the normal acetone/ 
HCl procedure. Chain separation of goldfish globin 
was achieved by chromatography on Sephacryl S200 
(30% acetic acid) following denaturation (8 M urea, 
pH 8.6) and o-chain disulfide polymer formation 
(oxidized in presence of dehydroascorbic acid) [ 161; 
for human globin chains by standard procedures [ 171. 
Aminoethylation [ 181, cyanogen bromide fragmenta- 
tion [ 193, citraconylation [20] and maleylation [2 l] 
were performed as indicated. Tryptic digestions 
(Sigma type XI, TPCK-treated enzyme) were done in 
0.2 M N-ethylmorpholine acetate (pH 8.0) using a 2% 
(w/w) protease ratio at 37°C and terminated by diluting 
into the starting buffer for the chromatographic sepa- 
ration. 
All glassware which came in contact with any of 
the solutions, for either the buffer or detection systems 
or the buffer-sample eluant following chromatography, 
was thoroughly washed in RBS-35 detergent (Fluka), 
rinsed in distilled water and ovendried. Solutions 
were maintained in dark glass bottles and either kept 
tightly closed or covered with aluminium foil. Acetic 
anhydride (0.2%) was included in all solutions; no 
smoking was allowed in the laboratory. The chemicals 
used, unless otherwise noted, were analytical grade 
from Fluka or Merck. Acetic acid, formic acid, 
1 -propanol and pyridine were each distilled over 
ninhydrin just prior to use. Amino acid analyses were 
performed on either a Durrum D-500 or a Liquimat III 
analyzer following 6 N HCl hydrolysis. 
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3. Results and discussion 
In primary structure analyses the isolation of pep- 
tides resulting from chemical or enzymatic cleavage 
has generally been a time consuming and tedious task 
at the micro-level (<50 nmol). Numerous authors 
[l-l I] have reported the use of HPLC in peptide- 
protein isolation. However, a major limitation of this 
technique in microsequence analysis has been the lack 
of an adequate detection system. The advantages or 
disadvantages of using fluorogenic reagents over 
ninhydrin, e.g., higher sensitivity [22], or either 
fluorescamine or OPA [23] for monitoring column 
eluants have also been the topics of various reports. 
However, conditions employed in such studies were 
often not optimal for the respective fluorogenic 
reagent, e.g., buffer system, presence of reducing 
agent and its concentration, presence of a detergent 
and its concentration, and temperature. Figure 1 
illustrates the presently achieved chromatographic 
separation of the tryptic peptides from the o-chain of 
goldfish hemoglobin and compares their detection 
with either fluorescamine (fig.1 A,B) or OPA (fig.lC). 
As noted [24] peaks detectable with fluorescamine 
are not necessarily detectable with OPA; similarly, 
their relative fluorescence yields are not necessarily 
comparable. 
Analyses of peptides obtained from a preparative 
isolation (fig.lA) at the 100 nmol level have shown, 
under conditions used for OPA detection, that 
peptides must contain the amino-group of lysine, 
consequently only fluorescamine has been utilized as 
the fluorogenic reagent. The reproducibility of the 
separation is shown in tig.lA,B. Chromatograms of 1 
and 100 nmol of tryptic peptides are identical, thus 
optimal conditions worked out with <l nmol of 
digested polypeptide can be used with confidence for 
the separation of preparative amounts of material 
(1 O-l 00 nmol). Overall yields as judged by amino 
acid analyses of the isolated peptides were between 
30-70%. In this case, however, no attempt was made 
to determine the extent of the trypsin digestion. 
Sequence analyses of >30 residues are readily 
obtained by the use of the modified Edman reagent 
DABITC in both the solid- and liquid-phase sequencers 
at the 5 and 20 nmol levels, respectively [ 14,151. It is 
therefore desirable to isolate large peptides, and 
examples of chromatograms of peptides obtained 
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Fig.1. HPLC separations of the tryptic peptides from o-chain 
of goldfish hemoglobin: (A) 100 nmol material, 2% analyzed 
with fluorescamine; (B) 1 nmol material, 10% analyzed with 
fluorescamine; (C) 1 nmol material, 10% analyzed with OPA. 
Chromatography was on a LiChrosorb RP 18 (10 pm particle 
size) column (4.6 X 250 mm) developed with a gradient 
(dark line) at 0.7 ml/min using as buffers (A) 0.5 M pyridine 
formate (pH 3.0) and (B) 1.0 M pyridine acetate (pH 5.5), 
60% (v/v) 1-propanol. See section 2 for description of the 
detection system. 
from limited tryptic digest, or cyanogen bromide 
cleavage, of both goldfish B- and human o-chains, are 
shown in fig.2-4. 
The separation of maleylated peptides from limited 
tryptic digestion of goldfish /Lglobin was performed 
with an equilibrium eluant at pH 5.5. At this pH all 
peptides were soluble (100 nmo1/500 d). Overall 
yields were 70% based on arginine content, and 3 pep- 
tides could, on the basis of amino acid analyses, be 
Fig.2. HPLC separation of the tryptic peptides from amino- 
ethylated and maleylated p-chain of goldfish hemoglobin. 
Chromatography was on a LiChrosorb RP 8 (10 pm particle 
size) column (4.6 X 250 mm) developed with a gradient 
(dark line) at 0.7 ml/mm with the buffers (A) 1.0 M pyridine 
acetate (pH 5.5) and (B) 1.0 M pyridine acetate (pH 5.5), 
60% (v/v) 1-propanol. 120 nmol digest applied and 1.7% of 
the eluant removed for detection with fluorescamine (see 
section 2). 
identified by comparison with the reported sequence 
of fl-globin from carp [ 161. The amino-terminal pep- 
tide, having all amino groups blocked by maleic 
anhydride produced no fluorescence, however from 
amino acid analysis of fraction B the peptide was 
obtained in 85Y0 yield. The separation of modified 
peptides is often a useful technique when problems 
of solubility are encountered. However in view of the 
small quantity of peptide needed for sequence analysis 
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Fig.3. Timed tryptic digestions of the citraconylated and aminoethylated a-chain of human hemoglobin. The conditions for 
chromatography on a LiChrosorb RP 18 column were as in fig.1. Trypsin (1% by wt) was added to 106 nmol a-chain derivative 
and the digestion performed at room temperature. At 0 mm (A), 2 mm (B) and 25 mm (C), 1% (1.06 nmol material) was chroma- 
tographed and 10% of the eluant removed for detection with fluorescamine (see section 2). 
(<20 nmol) and the relative large volumes for injection 
(0.5-l .O ml) insolubility in this procedure is less 
likely to be encountered than when working with 
material at higher concentration. 
The differential rates of polypeptide bond cleavage 
by either enzymatic or chemical agents can be utilized 
to generate fragments not normally obtained by 
extended times of reaction. An example of the optimi- 
zation of conditions for limited tryptic digestion, 
resulting in large fragments, is shown in fig.3 for 
citraconylated, aminoethylated human cr-globin. 
The speed and sensitivity of this system, in combi- 
nation with micro-sequencing using DABITC, is 
illustrated by the separation (fig.4) and subsequent 
sequence determinations on peptides obtained from 
the cyanogen bromide cleavage of 53 nmol of human 
aglobin. The yield and composition of each fragment 
are shown in table 1 and the sequence determinations 
Fig.4. Separation of the CNBr peptides from aminoethylated 
or-chain of human hemoglobin. The material (53 nmol) was 
chromatographed on a LiChrosorb RP18 column as in fig.2 
and 5% of the eluant removed for detection with fluorescamine 
(see section 2). 
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Table 1 
Amino acid compositions and yields of the CNBr fragments 
from human ol-globina 
Pool c Pool D Pool E cvClobin 
Lysine 2.7 (3) 3.6 (4) 3.0 (4) 10.5 (11) 
Histidine 0.9 (1) 3.2 (4) 4.3 (5) 10.1 (10) 
Arginine 0.6 (1) 0 (0) 1.4 (2) 2.5 (3) 
Aspartic acid 2.1 (2) 4.5 (5) 12.6 
Threonineb 
5.0 (5) (12) 
1.0 (1) 3.3 (4) 4.0 (4) 9.9 
Serineb 
(9) 
1.1 (1) 2.4 (3) 5.0 (7) 10.7 (11) 
Glutamic acid 2.9 (3) 1.4 (1) 1.1 (1) 6.0 (5) 
Proline 0.9 (1) 1.7 (2) 3.2 (4) 7.6 (7) 
Glycine 3.8 (4) 3.5 (3) 1.1 (1) 7.8 (7) 
Alanine 6.3 (7) 5.3 (5) 8.4 (9) 22.1 (21) 
CysteineC 0 (0) 0 (0) 1.0 (1) 0.9 (1) 
VaIine 2.5 (3) 3.6 (4) 5.8 (6) 12.6 
Methionined 
(13) 
1.0 (1) 0.9 (1) 0 (0) 1.9 (2) 
Isoleucine 0 (0) 0 (0) 0 (0) 0 (0) 
Leucine 1.9 (2) 2.9 (3) 10.9 (13) 17.1 (18) 
Tyrosine 1.1 (1) 0.9 (1) 1.0 (1) 2.7 (3) 
Phenylalanine 0 (0) 3.0 (4) 3.0 (3) 6.4 (7) 
Tryptophane 1.0 (1) 0 (0) 0 (0) 0.9 (1) 
% recovery 58.7 69.8 102.4 - 
a Pools C, D and E represent hose from fig.4 
b Corrected for 9% (Thr) and 7% (Ser) destruction during hydrolysis 
’ Detected as aminoethylcysteine; calculated in pool C using the tyrosine value and 
in cu-globin as 33% of arginine 
d Detected as homoserine and homoserine lactone; calculated in pools A and B 
using the tyrosine value and in cyglobin as 66% of arginine 
e Calculated in pool A using the tyrosine value and in cYglobin as 33% of arginine 
of fractions C and D by liquid- [ 151 and solid-phase References 
December 1979 
sequencers [ 141 are illustrated in the accompanying 
communications [ 14,151. We wish to emphasize that 
peptide separation was obtained in <l h and the 
resulting fractions (<4 ml) were dried in <l h by 
vortex evaporation. The techniques and instruments 
described here therefore provide rapid and sensitive 
methods for the isolation of and subsequent sequence 
analyses of peptides and/or proteins available in 
limited quantities. 
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